203 related articles for article (PubMed ID: 19584650)
1. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
Retina; 2009; 29(7):926-31. PubMed ID: 19584650
[TBL] [Abstract][Full Text] [Related]
2. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
[TBL] [Abstract][Full Text] [Related]
3. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage: a comparative study.
Jirawison C; Ittipunkul N
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S136-42. PubMed ID: 22696866
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Yeh PT; Yang CH; Yang CM
Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH; Chen MS
Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
[TBL] [Abstract][Full Text] [Related]
8. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
Yeoh J; Williams C; Allen P; Buttery R; Chiu D; Clark B; Essex R; McCombe M; Qureshi S; Campbell WG
Clin Exp Ophthalmol; 2008 Jul; 36(5):449-54. PubMed ID: 18942219
[TBL] [Abstract][Full Text] [Related]
9. The role of intraoperative bevacizumab for prevention of postoperative vitreous hemorrhage in diabetic vitreous hemorrhage.
Göncü T; Özdek S; Ünlü M
Eur J Ophthalmol; 2014; 24(1):88-93. PubMed ID: 23787453
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy.
Modarres M; Nazari H; Falavarjani KG; Naseripour M; Hashemi M; Parvaresh MM
Eur J Ophthalmol; 2009; 19(5):848-52. PubMed ID: 19787608
[TBL] [Abstract][Full Text] [Related]
11. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
[TBL] [Abstract][Full Text] [Related]
12. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
[TBL] [Abstract][Full Text] [Related]
13. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
[TBL] [Abstract][Full Text] [Related]
15. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
Gupta A; Bansal R; Gupta V; Dogra MR
Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
[TBL] [Abstract][Full Text] [Related]
16. Can an intraoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous hemorrhage?
Romano MR; Gibran SK; Marticorena J; Wong D; Heimann H
Eur J Ophthalmol; 2009; 19(4):618-21. PubMed ID: 19551678
[TBL] [Abstract][Full Text] [Related]
17. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.
Spaide RF; Fisher YL
Retina; 2006 Mar; 26(3):275-8. PubMed ID: 16508426
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
[TBL] [Abstract][Full Text] [Related]
20. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
